Groups | Alveolar collapse (%) | Contraction index | Mucus score | Tissue cellularity (%) | Collagen fibers (%) | α–smooth muscle actin (%) | |||
MN | PMN | Airways | Alveolar septa | Alveolar duct | Terminal bronchiole | ||||
CTRL-SAL | 3.3 ± 1.5 | 2.6 ± 0.07 | 0.0 ± 0.0 | 29.6 ± 3.0 | 1.2 ± 0.6 | 13.1 ± 4.0 | 1.7 ± 1.2 | 1.8 ± 0.4 | 2.0 ± 1.0 |
OVA-SAL | 25.9 ± 1.9* | 3.6 ± 0.2* | 2.7 ± 0.6* | 23.9 ± 2.3* | 12.1 ± 2.0* | 36.8 ± 18.4* | 5.8 ± 2.8* | 8.6 ± 2.8* | 10.1 ± 2.2* |
OVA-THY | 5.0 ± 1.2† | 2.3 ± 0.4† | 0.6 ± 0.4† | 24.3 ± 2.2 | 2.0 ± 0.7† | 13.0 ± 3.2† | 2.1 ± 1.6† | 4.7 ± 1.9† | 5.2 ± 1.6† |
CTRL-SAL, mice sensitized and challenged with saline, intratracheally treated with saline on day 47 and sacrificed on day 67; OVA-SAL, mice sensitized and challenged with OVA, intratracheally treated with saline on day 47 and sacrificed on day 67; OVA-THY, mice sensitized and challenged with OVA, intratracheally treated with thymulin-expressing nanoparticles (50 μg of plasmids/50 μl) on day 47 and sacrificed on day 67; MN, mononuclear cells; PMN, polymorphonuclear cells.
*Statistically significant difference (P < 0.05) compared to the CTRL-SAL group.
†Statistically significant difference (P < 0.05) compared to the OVA-SAL group.